Stay updated on Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial

Sign up to get notified when there's something new on the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T02:42:19.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1.0%
    Check dated 2025-06-19T19:18:00.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:06:16.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:49:49.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:56:01.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about the study on breast cancer treatments, specifically mentioning the drugs Ipilimumab and Nivolumab, and the involvement of various collaborators. The previous detailed description of the study's purpose and methodology has been removed.
    Difference
    36%
    Check dated 2025-04-16T02:07:39.000Z thumbnail image

Stay in the know with updates to Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page.